0000950170-24-061646.txt : 20240517
0000950170-24-061646.hdr.sgml : 20240517
20240517161143
ACCESSION NUMBER: 0000950170-24-061646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240516
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kumar Neil
CENTRAL INDEX KEY: 0001742485
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 24959784
MAIL ADDRESS:
STREET 1: C/O BRIDGEBIO PHARMA, INC.
STREET 2: 3160 PORTER DR, STE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
ownership.xml
4
X0508
4
2024-05-16
0001743881
BridgeBio Pharma, Inc.
BBIO
0001742485
Kumar Neil
C/O BRIDGEBIO PHARMA, INC.
3160 PORTER DR., SUITE 250
PALO ALTO
CA
94304
true
true
false
false
CEO and President
false
Common Stock
2024-05-16
4
M
false
60667
A
4928191
D
Common Stock
2024-05-16
4
F
false
30748
31.04
D
4897443
D
Common Stock
1012722
I
By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Common Stock
995686
I
By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Restricted Stock Units
2024-05-16
4
M
false
5130
0
D
Common Stock
5130
0
D
Restricted Stock Units
2024-05-16
4
M
false
2394
0
D
Common Stock
2394
7183
D
Restricted Stock Units
2024-05-16
4
M
false
33544
0
D
Common Stock
33544
368984
D
Restricted Stock Units
2024-05-16
4
M
false
19599
0
D
Common Stock
19599
293989
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 60,667 shares of Common Stock underlying the Reporting Person's RSUs.
The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
/s/ Brian C. Stephenson, Attorney-in-Fact
2024-05-17